| Walker, Craig M |
| Terminated | 4 | 43 | US | Varithena®, FDA-approved Endothermal Ablation (ETA) systems | Boston Scientific Corporation | Varicose Veins | 04/24 | 04/24 | | |
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease |
|
|
| Active, not recruiting | 3 | 17004 | Europe, Canada, Japan, US, RoW | Inclisiran sodium 300 mg, Placebo | Novartis Pharmaceuticals | Atherosclerotic Cardiovascular Disease | 10/27 | 10/27 | | |
STAND, NCT04025008: A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee |
|
|
| Not yet recruiting | N/A | 177 | US | MicroStent or percutaneous transluminal angioplasty (PTA) | Micro Medical Solution, Inc. | Peripheral Arterial Disease | 01/21 | 08/21 | | |
| Completed | N/A | 133 | US | AngioSafe Peripheral CTO Crossing System | AngioSafe, Inc., Veranex, Inc. | Peripheral Artery Occlusion, Peripheral Arterial Disease | 04/23 | 06/23 | | |
NCT03477604: A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee (STAND) |
|
|
| Active, not recruiting | N/A | 177 | US | MicroStent and Standard PTA, Standard PTA | Micro Medical Solution, Inc. | Peripheral Arterial Disease | 12/23 | 12/26 | | |
| Recruiting | N/A | 376 | Europe, US, RoW | SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities | 06/27 | 07/29 | | |
| Active, not recruiting | N/A | 418 | Europe, Canada, US, RoW | SELUTION SLR™ DEB, Control | M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation | Coronary Restenosis | 07/25 | 08/29 | | |
GREAT, NCT06321575: The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy ( Trial) |
|
|
| Recruiting | N/A | 159 | US | Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS) | Avantec Vascular, Bright Research Partners, Yale Cardiovascular Research Group | Peripheral Arterial Disease | 11/26 | 11/26 | | |
NCT06492733: FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW |
|
|
| Recruiting | N/A | 65 | US | FastWire System - Peripheral | Versono Medical Ltd | Chronic Total Occlusion of Artery of the Extremities | 01/25 | 02/25 | | |
| Recruiting | N/A | 300 | Europe, US, RoW | SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Superficial Femoral Artery Stenosis | 08/25 | 12/29 | | |
| Recruiting | N/A | 155 | US | Thor laser atherectomy, Thor calcium modification | Philips Clinical & Medical Affairs Global, NAMSA, Massachusetts General Hospital | Peripheral Artery Disease, Peripheral Artery Stenosis, Peripheral Artery Calcification, PAD | 10/26 | 11/27 | | |
| Recruiting | N/A | 50 | US | Shockwave Intravenous lithotripsy with a Supera stent | Cardiovascular Institute of the South Clinical Research Corporation, Shockwave Medical, Inc. | Peripheral Arterial Disease | 06/22 | 12/22 | | |
| Bernardo, Nelson |
| Recruiting | N/A | 376 | Europe, US, RoW | SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities | 06/27 | 07/29 | | |
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN |
|
|
| Recruiting | N/A | 1400 | Europe, US, RoW | Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation | Medtronic Vascular | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 11/26 | 11/29 | | |
| Recruiting | N/A | 300 | Europe, US, RoW | SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Superficial Femoral Artery Stenosis | 08/25 | 12/29 | | |
NCT04543539: IN.PACT™ AV Access Post-Approval Study (PAS002) |
|
|
| Active, not recruiting | N/A | 240 | US | IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort, IN.PACT™ AV Drug Coated Balloon (DCB) - Extended Cohort | Medtronic | Arteriovenous Fistula, Arteriovenous Fistula Stenosis, Arteriovenous Fistula Occlusion, Fistula | 02/25 | 02/29 | | |
| Kullmann, Stephanie |
NCT02991365: Effect of Weight Loss on Brain Insulin Sensitivity in Humans |
|
|
| Recruiting | N/A | 40 | Europe | nasal insulin, placebo spray | University Hospital Tuebingen | Insulin Resistance | 09/24 | 12/24 | | |
| Completed | N/A | 44 | Europe | transcranial direct current stimulation | University Hospital Tuebingen, German Center for Diabetes Research | Insulin Resistance, Transcranial Direct Current Stimulation, Obesity, Diabetes, Magnetic Resonance Imaging | 10/23 | 11/23 | | |
| Active, not recruiting | N/A | 40 | Europe | anodal transcranial direct current stimulation, anodal tDCS, excitatory tDCS, cathodal transcranial direct current stimulation, cathodal tDCS, inhibitory tDCS, sham transcranial direct current stimulation, sham tDCS | University Hospital Tuebingen | Insulin Resistance, Obesity, Diabetes Type 2 | 11/24 | 12/24 | | |
NCT06487832: Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness |
|
|
| Recruiting | N/A | 60 | Europe | Subcutaneous GLP1-RA, Subcutaneous placebo | University Hospital Tuebingen | Normal Weight, Overweight and Obesity, Insulin Sensitivity, Insulin Resistance | 07/27 | 12/27 | | |
| Recruiting | N/A | 40 | Europe | single bout of moderate intensity continuous training (MICT), single bout of High Intensity Interval Training (HIIT), waiting control | University Hospital Tuebingen | Insulin Resistance, Obesity | 12/26 | 12/26 | | |
| Droppa, Michal |
DOUBLE-CHOICE, NCT05036018: RanDOmized stUdy Comparing Both Latest Generation Self-Expanding Valves and a Minimalist approaCH vs. Standard Of Care In transCathEter Aortic Valve Implantation |
|
|
| Active, not recruiting | N/A | 836 | Europe | ACURATE neo2, minimalist approach, CoreValve Evolut Pro and Pro+, Standard of care | Leipzig Heart Science gGmbH, Heart Center Leipzig - University Hospital | Aortic Valve Stenosis | 02/25 | 12/33 | | |
| Recruiting | N/A | 180 | Europe | CeraFlex PFO Closure System | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale | 12/25 | 07/27 | | |
